Aravinda Nanjundappa, MD
Interventional Cardiology · Beckley, WVNPI 1447244488
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (35.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Medtronic at 33.0% of the total. Among interventional cardiology clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 523 payments — averaging $317.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$55K
- Recor Medical Inc$26K
- Argon Medical Devices, Inc.$15K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$13K
- Abbott$9K
- Shockwave Medical, Inc$8K
- plus $39K from 32 others
Across 271 payments — averaging $2600.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$181K
- Shockwave Medical, Inc$109K
- Abbott$88K
- Inari Medical, Inc.$83K
- Cardiovascular Systems Inc.$80K
- Edwards Lifesciences$73K
- plus $91K from 8 others
What the payments were for
- Consulting fees$52,64332%
- Speaking & faculty fees$59,00336%
- Travel & lodging$36,49522%
- Food & beverage$17,67911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 152 | $54,773 |
| Recor Medical Inc | 38 | $26,487 |
| Argon Medical Devices, Inc. | 24 | $15,323 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 56 | $12,793 |
| Abbott | 80 | $9,282 |
| Shockwave Medical, Inc | 19 | $8,370 |
| Livanova USA, Inc. | 4 | $7,288 |
| W. L. Gore & Associates, Inc. | 4 | $7,252 |
| Biotronik Inc. | 7 | $4,274 |
| Penumbra, Inc. | 18 | $3,962 |
| Philips North America LLC | 11 | $3,639 |
| Pfizer | 2 | $2,748 |
| Celonova Biosciences, Inc. | 2 | $2,386 |
| Teleflex LLC | 3 | $1,524 |
| Terumo Medical Corporation | 14 | $1,431 |
| Boston Scientific | 28 | $1,327 |
| Cook Medical LLC | 6 | $368 |
| Cardiovascular Systems Inc. | 21 | $320 |
| Medicure Pharma Inc. | 1 | $300 |
| Surmodics, Inc. | 4 | $243 |
| Abiomed | 3 | $204 |
| Osprey Medical Inc | 3 | $177 |
| Angiodynamics, Inc. | 3 | $168 |
| Inari Medical, Inc. | 3 | $156 |
| Bard Peripheral Vascular, Inc. | 2 | $138 |
| Contego Medical, Inc | 1 | $131 |
| Siemens Medical Solutions USA, Inc. | 1 | $130 |
| Cardinal Health 200 LLC | 1 | $97 |
| Amgen | 2 | $97 |
| Silk Road Medical, Inc. | 1 | $86 |
| Edwards Lifesciences | 1 | $78 |
| ZOLL Circulation Inc | 1 | $73 |
| Cvrx, Inc. | 1 | $72 |
| Novo Nordisk | 1 | $50 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Novartis | 1 | $15 |
| Asahi Intecc USA, Inc. | 1 | $15 |
| Cordis US CORP. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Paradise Ultrasound Renal Denervation System$21,458
- SYMPLICITY G3$17,955
- Clot Management$14,943
- LifeVest$11,812
- CoreValve Evolut$11,239
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$8,082
- TandemLife$7,267
- VIABAHN Endoprosthesis$7,132
- IN.PACT Admiral$6,403
- Diamondback Coronary$4,749
- PARADISE RENAL DENERVATION SYSTEM$4,279
- Abre$4,000
- AMPLATZER$3,500
- (9520) IGT Devices Undivided$3,250
- Indigo System$3,210
- ELIQUIS$2,748
- HawkOne$2,400
- Oscar$1,794
- GlideWire$987
- GENERAL - STENTS$611
How this compares
$165,821 in reported general payments places this provider in the 90th percentile of 46 interventional cardiology providers in West Virginia.
See all interventional cardiology providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 45 | $63,406 |
| EntrestoSacubitril/Valsartan | 32 | $36,863 |
| XareltoRivaroxaban | 15 | $16,945 |
| EliquisApixaban | 11 | $13,091 |
| BrilintaTicagrelor | 22 | $12,415 |
| Cilostazol | 93 | $3,104 |
| Rosuvastatin Calcium | 124 | $1,609 |
| Atorvastatin Calcium | 132 | $1,268 |
| Ezetimibe | 28 | $656 |
| ClopidogrelClopidogrel Bisulfate | 86 | $639 |
| Bupropion Hcl SrBupropion Hcl | 20 | $573 |
| Metoprolol Succinate | 49 | $480 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 36 | $382 |
| Valsartan | 13 | $374 |
| Losartan Potassium | 47 | $319 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $15 | $36,86332 claims |
| PfizerEliquis | $2,748 | $13,09111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 46 interventional cardiology providers in West Virginia.
Other interventional cardiology in Beckley
- Abdrhaman HamoBeckley$11K
- Melaku DemedeBeckley$8K
- Mark BatesCharleston$288K
- Elie GharibSouth Charleston$240K
- Wissam GharibMorgantown$179K
- Anene UkaigweCharleston$168K
- Daniel SnavelyHuntington$120K
- Elise AndersonCharleston$38K
- Richard HanCharleston$38K
- Mehrette MaruHuntington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.